Home › Funds › ABN AMRO INVESTMENT SOLUTIONS › JNJ

ABN AMRO INVESTMENT SOLUTIONS position in JNJ

JOHNSON & JOHNSON · Health Care

ABN AMRO INVESTMENT SOLUTIONS reported holding 326,751 shares of JNJ (JOHNSON & JOHNSON) in its Q3 2026 13F filing — a position valued at US$86.5M, representing 0.66% of its reported portfolio and ranking #32 among its reported holdings. ABN AMRO INVESTMENT SOLUTIONS has disclosed JNJ holdings in 13 of the last 13 reported quarters, going back to Q3 2023.

Latest position (Q3 2026)326.75K sh
Reported value held$86.50M
Portfolio Weight0.66%
First reportedQ3 2023
Last changeAdd
Updated2026-11-13

Last updated: 2026-11-13 · Source: SEC EDGAR Form 13F-HR

How ABN AMRO INVESTMENT SOLUTIONS's JNJ position evolved

ABN AMRO INVESTMENT SOLUTIONS first disclosed a stake in JNJ in Q3 2023 at 104,940 shares (US$16.3M). The position peaked in Q3 2026 at 326,751 shares, worth US$86.5M. Across 13 filings, ABN AMRO INVESTMENT SOLUTIONS increased the stake 8 time(s), trimmed it 4 time(s) and left it unchanged 0 time(s). The most recent filing (Q3 2026) shows 326,751 shares valued at US$86.5M — an increase of 56,437 shares quarter over quarter.. Notable position changes include a 32% trim in Q3 2025 (shares rose 11% over the following quarter), a 67% increase in Q4 2025 (shares rose 18% over the following quarter), a 64% increase in Q2 2026 (shares rose 4% over the following quarter).

Quarter by quarter

QuarterSharesValueChange
Q3 2023 104.94K $16.34M New
Q4 2023 99.40K $15.58M Reduce
Q1 2024 108.60K $17.18M Add
Q2 2024 126.35K $18.47M Add
Q3 2024 129.04K $20.91M Add
Q4 2024 122.83K $17.76M Reduce
Q1 2025 146.14K $24.24M Add
Q2 2025 135.59K $20.71M Reduce
Q3 2025 92.69K $17.19M Reduce
Q4 2025 154.85K $32.05M Add
Q1 2026 164.37K $40.18M Add
Q2 2026 270.31K $68.65M Add
Q3 2026 326.75K $86.50M Add

Dots on the line are colored by change type; missing quarters mean no position was reported.

About JNJ and 13F data

JNJ (JOHNSON & JOHNSON) is a Health Care company. 32 other funds we track also report a position in JNJ — the largest reported positions include BlackRock Inc (US$53.87B), Vanguard Group (US$49.74B), VANGUARD CAPITAL MANAGEMENT LLC (US$41.76B). Under SEC rules, institutional investment managers with over $100M in assets must file Form 13F within 45 days of each quarter-end, disclosing long positions in US-listed equities. The data excludes short positions, most options and foreign holdings, so treat it as a quarterly snapshot rather than a live position.

Other funds holding JNJ

All JNJ fund holders →

FAQ

How long has ABN AMRO INVESTMENT SOLUTIONS held JNJ?

ABN AMRO INVESTMENT SOLUTIONS has disclosed JNJ holdings in 13 of the last 13 reported quarters, going back to Q3 2023.

What is ABN AMRO INVESTMENT SOLUTIONS's current position in JNJ?

As of Q3 2026, ABN AMRO INVESTMENT SOLUTIONS holds 326.75K shares of JNJ (JOHNSON & JOHNSON), valued at $86.50M, representing 0.66% of its reported portfolio and ranking #32.

Has ABN AMRO INVESTMENT SOLUTIONS been buying or selling JNJ?

In the latest 13F filing (Q3 2026), ABN AMRO INVESTMENT SOLUTIONS increased its position in JNJ. The position peaked in Q3 2026 at 326.75K shares.

Which other funds hold JNJ?

Other major institutional holders of JNJ include BlackRock Inc, Vanguard Group, VANGUARD CAPITAL MANAGEMENT LLC, among 32 funds with disclosed positions.

Where does this data come from?

All figures are computed from SEC Form 13F quarterly filings, which institutional investment managers must file within 45 days of quarter end for long positions of $100,000 or more.